Caseware UK (AP4) 2024.0.164 2024.0.164 2025-01-312025-01-312024-02-01trueThe principal activity of the company is the sale of beauty products.false14trueThe members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.false 09940444 2024-02-01 2025-01-31 09940444 2023-02-01 2024-01-31 09940444 2025-01-31 09940444 2024-01-31 09940444 c:Director1 2024-02-01 2025-01-31 09940444 d:OfficeEquipment 2024-02-01 2025-01-31 09940444 d:OfficeEquipment 2025-01-31 09940444 d:OfficeEquipment 2024-01-31 09940444 d:OfficeEquipment d:OwnedOrFreeholdAssets 2024-02-01 2025-01-31 09940444 d:CurrentFinancialInstruments 2025-01-31 09940444 d:CurrentFinancialInstruments 2024-01-31 09940444 d:CurrentFinancialInstruments d:WithinOneYear 2025-01-31 09940444 d:CurrentFinancialInstruments d:WithinOneYear 2024-01-31 09940444 d:ShareCapital 2025-01-31 09940444 d:ShareCapital 2024-01-31 09940444 d:RetainedEarningsAccumulatedLosses 2025-01-31 09940444 d:RetainedEarningsAccumulatedLosses 2024-01-31 09940444 c:OrdinaryShareClass1 2024-02-01 2025-01-31 09940444 c:OrdinaryShareClass1 2025-01-31 09940444 c:OrdinaryShareClass1 2024-01-31 09940444 c:FRS102 2024-02-01 2025-01-31 09940444 c:AuditExempt-NoAccountantsReport 2024-02-01 2025-01-31 09940444 c:FullAccounts 2024-02-01 2025-01-31 09940444 c:PrivateLimitedCompanyLtd 2024-02-01 2025-01-31 09940444 2 2024-02-01 2025-01-31 09940444 e:PoundSterling 2024-02-01 2025-01-31 xbrli:shares iso4217:GBP xbrli:pure

Registered number: 09940444









COSMETIPS LTD







UNAUDITED

FINANCIAL STATEMENTS

INFORMATION FOR FILING WITH THE REGISTRAR

FOR THE YEAR ENDED 31 JANUARY 2025

 
COSMETIPS LTD
REGISTERED NUMBER: 09940444

BALANCE SHEET
AS AT 31 JANUARY 2025

2025
2024
Note
£
£

Fixed assets
  

Tangible assets
 4 
4,128
9,716

  
4,128
9,716

Current assets
  

Debtors: amounts falling due within one year
 5 
23,684
34,151

Cash at bank and in hand
 6 
161,688
238,824

  
185,372
272,975

Creditors: amounts falling due within one year
 7 
(126,614)
(147,422)

Net current assets
  
 
 
58,758
 
 
125,553

Total assets less current liabilities
  
62,886
135,269

  

Net assets
  
62,886
135,269


Capital and reserves
  

Called up share capital 
 8 
100
100

Profit and loss account
  
62,786
135,169

  
62,886
135,269


Page 1

 
COSMETIPS LTD
REGISTERED NUMBER: 09940444
    
BALANCE SHEET (CONTINUED)
AS AT 31 JANUARY 2025

The director considers that the Company is entitled to exemption from audit under section 477 of the Companies Act 2006 and members have not required the Company to obtain an audit for the year in question in accordance with section 476 of the Companies Act 2006.

The director acknowledges her responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.

The financial statements have been prepared in accordance with the provisions applicable to companies subject to the small companies regime and in accordance with the provisions of FRS 102 Section 1A - small entities.

The financial statements have been delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The Company has opted not to file the statement of comprehensive income in accordance with provisions applicable to companies subject to the small companies' regime.

The financial statements were approved and authorised for issue by the board and were signed on its behalf by: 




J C Aaron
Director

Date: 7 October 2025

The notes on pages 3 to 7 form part of these financial statements.

Page 2

 
COSMETIPS LTD
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 JANUARY 2025

1.


General information

Cosmetips Limited is a private company, limited by shares and incorporated in England and Wales (registered number: 09940444). The registered office is 101 New Cavendish Street, 1st Floor South, London, W1W 6XH.
The financial statements are presented in Sterling, which is the functional currency of the company.
The principal activity of the Company continued to be the sale of beauty products.

2.Accounting policies

 
2.1

Basis of preparation of financial statements

The financial statements have been prepared under the historical cost convention unless otherwise specified within these accounting policies and in accordance with FRS 102 'The Financial Reporting Standard applicable in the UK and the Republic of Ireland' and the requirements of the Companies Act 2006. The disclosure requirements of Section 1A of FRS 102 have been applied other than where additional disclosure is required to show a true and fair view.

The following principal accounting policies have been applied:

 
2.2

Foreign currency translation

Functional and presentation currency

The Company's functional and presentational currency is GBP.

Transactions and balances

Foreign currency transactions are translated into the functional currency using the spot exchange rates at the dates of the transactions.

At each period end foreign currency monetary items are translated using the closing rate. Non-monetary items measured at historical cost are translated using the exchange rate at the date of the transaction and non-monetary items measured at fair value are measured using the exchange rate when fair value was determined.

Foreign exchange gains and losses resulting from the settlement of transactions and from the translation at period-end exchange rates of monetary assets and liabilities denominated in foreign currencies are recognised in profit or loss except when deferred in other comprehensive income as qualifying cash flow hedges.

Foreign exchange gains and losses that relate to borrowings and cash and cash equivalents are presented in the Statement of Comprehensive Income within 'finance income or costs'. All other foreign exchange gains and losses are presented in profit or loss within 'other operating income'.

Page 3

 
COSMETIPS LTD
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 JANUARY 2025

2.Accounting policies (continued)

 
2.3

Revenue

Revenue is recognised to the extent that it is probable that the economic benefits will flow to the Company and the revenue can be reliably measured. Revenue is measured as the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes. The following criteria must also be met before revenue is recognised:

Sale of goods

Revenue from the sale of goods is recognised when all of the following conditions are satisfied:
the Company has transferred the significant risks and rewards of ownership to the buyer;
the Company retains neither continuing managerial involvement to the degree usually associated with ownership nor effective control over the goods sold;
the amount of revenue can be measured reliably;
it is probable that the Company will receive the consideration due under the transaction; and
the costs incurred or to be incurred in respect of the transaction can be measured reliably.

 
2.4

Research and development

In the research phase of an internal project it is not possible to demonstrate that the project will generate future economic benefits and hence all expenditure on research shall be recognised as an expense when it is incurred. Intangible assets are recognised from the development phase of a project if and only if certain specific criteria are met in order to demonstrate the asset will generate probable future economic benefits and that its cost can be reliably measured. The capitalised development costs are subsequently amortised on a straight-line basis over their useful economic lives, which range from 3 to 6 years.
If it is not possible to distinguish between the research phase and the development phase of an internal project, the expenditure is treated as if it were all incurred in the research phase only.

 
2.5

Interest income

Interest income is recognised in profit or loss using the effective interest method.

 
2.6

Finance costs

Finance costs are charged to profit or loss over the term of the debt using the effective interest method so that the amount charged is at a constant rate on the carrying amount. Issue costs are initially recognised as a reduction in the proceeds of the associated capital instrument.

 
2.7

Taxation

Tax is recognised in profit or loss except that a charge attributable to an item of income and expense recognised as other comprehensive income or to an item recognised directly in equity is also recognised in other comprehensive income or directly in equity respectively.

The current income tax charge is calculated on the basis of tax rates and laws that have been enacted or substantively enacted by the balance sheet date in the countries where the Company operates and generates income.


Page 4

 
COSMETIPS LTD
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 JANUARY 2025

2.Accounting policies (continued)

 
2.8

Tangible fixed assets

Tangible fixed assets under the cost model are stated at historical cost less accumulated depreciation and any accumulated impairment losses. Historical cost includes expenditure that is directly attributable to bringing the asset to the location and condition necessary for it to be capable of operating in the manner intended by management.

Depreciation is charged so as to allocate the cost of assets less their residual value over their estimated useful lives, using the straight-line method.

Depreciation is provided on the following basis:

Office equipment
-
3 years

The assets' residual values, useful lives and depreciation methods are reviewed, and adjusted prospectively if appropriate, or if there is an indication of a significant change since the last reporting date.

Gains and losses on disposals are determined by comparing the proceeds with the carrying amount and are recognised in profit or loss.

 
2.9

Debtors

Short-term debtors are measured at transaction price, less any impairment. Loans receivable are measured initially at fair value, net of transaction costs, and are measured subsequently at amortised cost using the effective interest method, less any impairment.

 
2.10

Cash and cash equivalents

Cash is represented by cash in hand and deposits with financial institutions repayable without penalty on notice of not more than 24 hours. Cash equivalents are highly liquid investments that mature in no more than three months from the date of acquisition and that are readily convertible to known amounts of cash with insignificant risk of change in value.

 
2.11

Creditors

Short-term creditors are measured at the transaction price. Other financial liabilities, including bank loans, are measured initially at fair value, net of transaction costs, and are measured subsequently at amortised cost using the effective interest method.

 
2.12

Dividends

Equity dividends are recognised when they become legally payable. Interim equity dividends are recognised when paid. Final equity dividends are recognised when approved by the shareholders at an annual general meeting.


3.


Employees

The average monthly number of employees, including directors, during the year was 1 (2024 - 4).

Page 5

 
COSMETIPS LTD
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 JANUARY 2025

4.


Tangible fixed assets





Office equipment

£



Cost or valuation


At 1 February 2024
33,682



At 31 January 2025

33,682



Depreciation


At 1 February 2024
23,967


Charge for the year on owned assets
5,587



At 31 January 2025

29,554



Net book value



At 31 January 2025
4,128



At 31 January 2024
9,716

Page 6

 
COSMETIPS LTD
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 JANUARY 2025

5.


Debtors

2025
2024
£
£


Trade debtors
3,744
-

Other debtors
17,137
18,946

Prepayments and accrued income
2,803
15,205

23,684
34,151



6.


Cash and cash equivalents

2025
2024
£
£

Cash at bank and in hand
161,688
238,824

161,688
238,824



7.


Creditors: Amounts falling due within one year

2025
2024
£
£

Trade creditors
494
-

Corporation tax
-
14,519

Other taxation and social security
-
4,634

Other creditors
123,620
125,769

Accruals and deferred income
2,500
2,500

126,614
147,422



8.


Share capital

2025
2024
£
£
Allotted, called up and fully paid



10,000 (2024 - 10,000) Ordinary shares of £0.01 each
100
100


 
Page 7